Evidence map›Paper›PMID 42546195›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Optimizing infectious disease mitigation under dynamic conditions.

Laura Müller, Fabio Sartori, Jonas Dehning, Maximilian F Eggl, Viola Priesemann

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Optimizing infectious disease mitigation under dynamic conditions.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Mechanics of pandemics.EClinicalMedicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laura MüllerMax-Planck-Institute for Dynamics and Self-Organization, Göttingen 37077, Germany.ORCID 0009-0000-2606-1117
Fabio SartoriMax-Planck-Institute for Dynamics and Self-Organization, Göttingen 37077, Germany.
Jonas DehningMax-Planck-Institute for Dynamics and Self-Organization, Göttingen 37077, Germany.
Maximilian F EgglInstitute of Neuroscience, Consejo Superior de Investigaciones Científicas - Universidad de Miguel Hernandez, Alicante 03550, Spain.
Viola PriesemannMax-Planck-Institute for Dynamics and Self-Organization, Göttingen 37077, Germany.ORCID 0000-0001-8905-5873

Funding

Bundesministerium für Forschung, Technologie und Raumfahrt (BMBF) 031L0298Bundesministerium für Forschung, Technologie und Raumfahrt (BMBF) 031L0300ADeutsche Forschungsgemeinschaft (DFG) 2067/1-390729940'la Caixa' Foundation ('la Caixa') LCF/BQ/PI23/11970039
6 · The paper itself

Abstract

Mitigation measures are essential for controlling the spread of infectious diseases during pandemics and epidemics, but they impose considerable societal, individual, and economic costs. We developed a general framework that combines simulation of disease dynamics with optimal control to determine mitigation strategies that balance infection and mitigation costs. Optimizing this trade-off, we identified three surprising effects: first, assuming a constant reproduction number [Formula: see text], the optimal response is typically "all-or-nothing": depending on disease severity, either strict mitigation or none at all is optimal, with intermediate levels emerging only in restricted regimes that we characterize analytically. Second, under seasonal variations, optimal mitigation is stricter during winter. Interestingly, a single wave of infections still arises in spring, replacing the autumn/winter waves known for classical influenza. Third, during steady vaccination campaigns, even optimal mitigation can result in transient infection waves. Finally, we quantify the cost of delayed mitigation onset and show that even short delays can substantially increase total costs-if the disease is severe. Overall, our framework is easily applicable to general and complex settings and thereby presents a versatile tool to explore optimal mitigation strategies for endemic and pandemic infectious disease.

Indexed as

Communicable Disease ControlCommunicable DiseasesPandemicsComputer SimulationHumansInfluenza, HumanSeasonsVaccinationoptimal controloptimizationpandemic mitigationpublic healthseasonality

Identifiers

PMID42546195
PMCPMC13462870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.